Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 39.97B | 39.73B | 39.57B | 36.74B | 35.64B |
Gross Profit | 11.99B | 12.07B | 11.61B | 10.73B | 10.04B |
EBITDA | 3.36B | 3.66B | 2.84B | 2.56B | 2.22B |
Net Income | 1.47B | 1.70B | 1.48B | 1.14B | 915.00M |
Balance Sheet | |||||
Total Assets | 53.24B | 54.08B | 50.76B | 49.38B | 47.52B |
Cash, Cash Equivalents and Short-Term Investments | 14.18B | 11.20B | 12.12B | 12.34B | 11.53B |
Total Debt | 1.58B | 1.19B | 668.00M | 691.00M | 697.00M |
Total Liabilities | 15.72B | 16.91B | 16.51B | 16.13B | 15.23B |
Stockholders Equity | 36.60B | 36.33B | 33.52B | 32.60B | 31.69B |
Cash Flow | |||||
Free Cash Flow | 3.64B | 24.00M | 891.00M | 1.30B | 1.80B |
Operating Cash Flow | 4.43B | 795.00M | 1.78B | 2.06B | 2.59B |
Investing Cash Flow | -381.00M | -817.00M | -908.00M | -753.00M | -777.00M |
Financing Cash Flow | -1.15B | -978.00M | -1.19B | -631.00M | -626.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥27.84B | 8.82 | 4.96% | 5.35% | 18.24% | ||
74 Outperform | ¥11.83B | 8.29 | 3.36% | 7.70% | 13.39% | ||
74 Outperform | ¥13.62B | 8.08 | 2.61% | -3.18% | -10.09% | ||
73 Outperform | ¥17.61B | 11.68 | 3.02% | 0.60% | -13.74% | ||
71 Outperform | ¥257.47B | 14.37 | 8.45% | 2.83% | 6.40% | 12.21% | |
54 Neutral | ¥19.63B | ― | 3.99% | -0.87% | -288.95% | ||
51 Neutral | ¥20.50B | 21.76 | 4.40% | -7.42% | -317.17% |